You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Papillomavirus

Showing 1 - 25 of 1,306
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Serum Galectin-3 as a Marker of Human Papillomavirus Infection

Completed
  • Human Papillomavirus Infection
  • cryotherapy
  • serum Galectin-3 assay
  • Assiut, Egypt
    Assiut University
Aug 17, 2023

Women's Values in Managing Human Papillomavirus (HPV)

Not yet recruiting
  • Human Papilloma Virus Infection
  • No intervention
  • (no location specified)
Nov 6, 2023

Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Human Papillomavirus Infection Trial in United States (Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant

Active, not recruiting
  • Human Papillomavirus Infection
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +5 more
Jan 26, 2023

Clinical Implications of HPV Infection in Male IBD Patients

Not yet recruiting
  • HPV Infection
  • +2 more
  • Anal pap smear and oral swab for cytology and HPV testing
  • Barcelona, Spain
    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sa
Jun 26, 2023

Human Papillomavirus in Young People Epidemiological Research 4

Not yet recruiting
  • Human Papillomavirus Infection
  • +6 more
    • (no location specified)
    Oct 17, 2022

    Human Papillomavirus in Young People Epidemiological Research 3

    Not yet recruiting
    • Human Papillomavirus Infection
    • +6 more
      • (no location specified)
      Oct 17, 2022

      Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

      Completed
      • Human Papilloma Virus Infection
      • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
      • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
      • Nanjing, Jiangsu, China
        CDC, Jiangsu Province
      Jan 12, 2023

      Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)

      Not yet recruiting
      • HPV Infection
      • Urine Sample Collection
      • +2 more
      • Dhaka, Bangladesh
      • +7 more
      Nov 10, 2023

      Human Papillomavirus-Related Carcinoma Trial in Seattle (Discussion, Educational Activity, Healthcare Activity)

      Recruiting
      • Human Papillomavirus-Related Carcinoma
      • Discussion
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Apr 26, 2023

      Warts Trial in Salt Lake City (Human Papillomavirus 9-valent Vaccine, Recombinant, Normal Saline)

      Not yet recruiting
      • Warts
      • Human Papillomavirus 9-valent Vaccine, Recombinant
      • Normal Saline
      • Salt Lake City, Utah
      • +1 more
      Nov 23, 2022

      Cervical Carcinoma, Human Papillomavirus Infection Trial in Liberia (Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis

      Enrolling by invitation
      • Cervical Carcinoma
      • Human Papillomavirus Infection
      • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
      • +3 more
      • Liberia, Guanacaste, Costa Rica
        Agencia Costarricense de Investigaciones Biomédicas - Fundación
      Aug 11, 2022

      Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

      Recruiting
      • Head and Neck Carcinoma
      • Adult Disease
      • HPVDC injection level dose 1
      • +3 more
      • Villejuif, France
        Gustave Roussy
      Aug 17, 2023

      Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

      Completed
      Has Results
      • Human Papillomavirus (HPV)-Related Malignancies
      • Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
      • Basking Ridge, New Jersey
      • +5 more
      Dec 14, 2022

      Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)

      Active, not recruiting
      • Human Papillomavirus Infection
      • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
      • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
      • Guangzhou, Guangdong, China
      • +2 more
      Dec 30, 2022

      HPV Associated Cancers Trial in New York, Houston (TGN-S11, Pembrolizumab)

      Not yet recruiting
      • HPV Associated Cancers
      • New York, New York
      • +1 more
      Apr 25, 2023

      Recurrent Respiratory Papillomatosis, Papillomavirus Infections, Papillomaviridae Trial run by the PGEN Therapeutics, Inc., a

      Recruiting
      • Recurrent Respiratory Papillomatosis
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 5, 2023

      Verruca Plantaris Trial in Surrey (Sterile water foot bath, Nitric Oxide)

      Not yet recruiting
      • Verruca Plantaris
      • Sterile water foot bath
      • Nitric Oxide
      • Surrey, British Columbia, Canada
        Achilles Foot Health Centre
      May 26, 2023

      Probiotic, Human Papillomavirus Infection, Pap Smear, Microbiome Trial in Kaohsiung (probiotic:Lactobacillus crispatus)

      Recruiting
      • Probiotic, Human Papillomavirus Infection, Pap Smear, Microbiome
      • probiotic:Lactobacillus crispatus
      • Kaohsiung, Taiwan
        Kaohsiung Chang Gung Memorial Hospital
      Aug 14, 2023

      Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)

      Not yet recruiting
      • Human Papillomavirus Infection
      • Human papillomavirus (HPV) Vaccine
      • Placebo
      • Canberra, Australia
        Paratus Clinical Research Canberra
      Jan 4, 2023

      Human Papillomavirus-Related Carcinoma Trial in Columbus (Educational Intervention, Informational Intervention, Survey

      Recruiting
      • Human Papillomavirus-Related Carcinoma
      • Educational Intervention
      • +2 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      May 9, 2022

      HPV Infection, Sexually Transmitted Infections and Anal

      Not yet recruiting
      • Human Papillomavirus Infection
      • +2 more
        • (no location specified)
        Aug 1, 2023

        Individuals Who Have Experienced Sexual Trauma

        Not yet recruiting
        • Cervical Carcinoma
        • Human Papillomavirus Infection
        • HPV Self-Collection
        • +2 more
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Jul 12, 2022

        HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Orange (Intensity-Modulated Radiation Therapy (IMRT))

        Recruiting
        • HPV Positive Oropharyngeal Squamous Cell Carcinoma
        • Intensity-Modulated Radiation Therapy (IMRT)
        • Orange, California
          Chao Family Comprehensive Cancer Center, University of Californi
        Nov 4, 2022

        High Grade Intraepithelial Trial (HPV detection test)

        Not yet recruiting
        • High Grade Intraepithelial
        • HPV detection test
        • (no location specified)
        Jul 7, 2022